<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03355937</url>
  </required_header>
  <id_info>
    <org_study_id>Ob&amp;Gyn Fulya</org_study_id>
    <nct_id>NCT03355937</nct_id>
  </id_info>
  <brief_title>Using Microfluidic Separation Sperm Selection for Unexplained Infertility and Reccurrent Implantation Failure</brief_title>
  <official_title>The Effects of Using Microfluidic Separation Sperm Selection for Unexplained Infertility(UEI) and Reccurrent Implantation Failure(RIF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acibadem University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acibadem University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to increase the likelihood of achieving IVF-treated pregnancy, good quality embryo
      transfer is important. To get good quality embryos, good quality gametes are needed. The
      selection of sperm is regulated according to the changing and mobility characteristics of
      today's conditions. The choice of multi-fluid sperm is thought to provide better sperm to
      obtain the environment in physiological conditions. Better embryo transfer to achieve better
      sperm elongation will increase the likelihood of pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be treated with conventional IVF treatment. A vaginal ultrasound (US)
      examination will be perform on day 3 of the cycle for assessment of ovarian size and to
      exclude patients with large ovarian cysts. If a cyst &gt;20 mm is present, the cycle will
      cancel. At an initial dose of 225 IU, hMG will be given daily by IM injection commencing on
      day 3 of the cycle. The dose will be adjusted as re- quired depending on the E2 (estradiol)
      level. Daily endovaginal US examinations for follicle growth assessment will be started when
      the E2 level reached 275 pg/mL (1,000 pmoljL). When at least two follicles would reach 18 mm
      in diameter, 5,000 IU of hCG will be administered intramuscularly. Oocyte retrieval will be
      performed vaginally under US guidance 36 hours later. Sperm for ICSI procedure of oocytes
      will be prepared by a standard swim-up technique using for control group and sperm chip
      method will be used for study group for Unexplained Infertility and Recurrent Implantation
      Failure group. Uterine transfer of embryos will be carry out fifth day after oocyte retrieval
      using a catheter.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>36 month</time_frame>
    <description>Clinical pregnancy includes intrauterine gestation (pres- ence of a gestational sac on ultrasonography), ectopic preg- nancy, and miscarriage diagnosed by histology.Cycles with only a positive pregnancy test (biochemical pregnancy) are not considered to have a clinical pregnancy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Live Birth Rate</measure>
    <time_frame>36 month</time_frame>
    <description>A delivery is the birth of one or more infants, either living or not, after 20 weeks of gestation. A live birth is a delivery that results in at least one living infant</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Abortion Rate</measure>
    <time_frame>36 month</time_frame>
    <description>Pregnancy loss includes miscarriage and therapeutic abor- tion of a clinical intrauterine pregnancy occurring at %20 weeks of gestation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implantation Rate</measure>
    <time_frame>36 month</time_frame>
    <description>Implantation rate is the number of gestational sacs observed on ultrasonog- raphy, divided by the number of embryos transferred.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Unexplained Infertility</condition>
  <condition>Recurrent Implantation Failure</condition>
  <arm_group>
    <arm_group_label>UEI Sperm Chip (-)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional IVF treatment and using conventional sperm selection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UEI Sperm Chip (+)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conventional IVF treatment and using sperm chip for sperm selection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RIF sperm chip (-)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional IVF treatment and using conventional sperm selection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RIF sperm chip (+)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conventional IVF treatment and using sperm chip for sperm selection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sperm Chip</intervention_name>
    <description>Sperm selection using by conventional or with sperm chip</description>
    <arm_group_label>UEI Sperm Chip (-)</arm_group_label>
    <arm_group_label>UEI Sperm Chip (+)</arm_group_label>
    <arm_group_label>RIF sperm chip (-)</arm_group_label>
    <arm_group_label>RIF sperm chip (+)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Unexplained Infertility Group; The inclusion criteria are;

          1. normal HSG,

          2. normal hormone levels,

          3. normal over functions,

          4. having normal uterine cavity and endometrial thickness determined by office
             hysteroscopy

          5. no endometriosis (determined by transvaginal ultrasonography and / or diagnostic
             laparoscopy)

          6. normal spermiogram result Recurrent Implantation Failure The inclusion criteria are;

        1-The inclusion criteria of the working group are: 2-Failure of embryo transfer at least
        twice after high quality embryo transfer after 3-IVF treatment, 4-having normal hormone
        reserve (FSH &lt;8 mIU / mL), 5-respond well to hormone stimulation (&gt; 8 oocyte collection),
        6-having normal uterine cavity and endometrial thickness determined by office hysteroscopy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Murat Dogan</last_name>
    <phone>00905056139577</phone>
    <email>muratdogan1984@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ercan Bastu</last_name>
    <phone>00905324134195</phone>
    <email>dr.ercanbastu@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Acibadem Fulya Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>Besiktas</state>
        <zip>34349</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Murat Dogan</last_name>
      <phone>005056139577</phone>
      <email>muratdogan1984@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Murat Dogan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Tasoglu S, Safaee H, Zhang X, Kingsley JL, Catalano PN, Gurkan UA, Nureddin A, Kayaalp E, Anchan RM, Maas RL, TÃ¼zel E, Demirci U. Exhaustion of racing sperm in nature-mimicking microfluidic channels during sorting. Small. 2013 Oct 25;9(20):3374-84. doi: 10.1002/smll.201300020. Epub 2013 May 16.</citation>
    <PMID>23677651</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2017</study_first_submitted>
  <study_first_submitted_qc>November 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2017</study_first_posted>
  <last_update_submitted>November 22, 2017</last_update_submitted>
  <last_update_submitted_qc>November 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Acibadem University</investigator_affiliation>
    <investigator_full_name>Murat Dogan</investigator_full_name>
    <investigator_title>Principal Ä°nvestigator</investigator_title>
  </responsible_party>
  <keyword>unexplained infertility</keyword>
  <keyword>recurrent implantation failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

